A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal Cancer

NCT06292689 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Vulvar and Vaginal Cancer

Interventions

DRUG: Cardunolizumab

Sponsor

Zhejiang Cancer Hospital

Collaborators

[object Object]
[object Object]